Jeff Marc Goldberg

Insider Reports History

Location
Cambridge, MA
Signature
/s/ James Kastenmayer, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeff Marc Goldberg:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aeglea BioTherapeutics, Inc. President and CEO, Director Employee Stock Option (right to buy) 1,884,838 29 Nov 2022 Direct

Insider Reports Filed by Jeff Marc Goldberg

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SYRE Aeglea BioTherapeutics, Inc. 29 Nov 2022 1 $0 4 President and CEO, Director 01 Dec 2022, 19:47
SYRE Aeglea BioTherapeutics, Inc. 29 Nov 2022 0 $0 3 President and CEO, Director 01 Dec 2022, 19:46